Svelte Medical Systems

Developer of drug eluting coronary stents

placeNew Providence, New Jersey, United States calendar_todayFounded 2007 groups3 employees language sveltemedical.com

Registered entities

Innovation

7 patent families (3 granted) — focus: Human necessities; filing pace dormant. Cited 566 times.

YearFilings
20125
20131
20152
20162
20171
20191

Investor mix

7 investors on record; lead investors include Apjohn Ventures Fund, Clark Enterprises, New Science Ventures, Norwich Ventures.

Investor typeCountShare
Venture capital343%
Private equity229%
Angel & family office114%
Other / undisclosed114%
Coming soon